Standard
Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease. / Frikke-Schmidt, Ruth; Hegazy, Sharif H.; Rasmussen, Ida Juul; Nordestgaard, Børge G.; Tybjærg-Hansen, Anne; Thomassen, Jesper Qvist.
In:
Alzheimer's and Dementia, Vol. 18, No. 12, 2022, p. 2734-2735.
Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Frikke-Schmidt, R, Hegazy, SH, Rasmussen, IJ
, Nordestgaard, BG, Tybjærg-Hansen, A & Thomassen, JQ 2022, '
Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease',
Alzheimer's and Dementia, vol. 18, no. 12, pp. 2734-2735.
https://doi.org/10.1002/alz.12742
APA
Frikke-Schmidt, R., Hegazy, S. H., Rasmussen, I. J.
, Nordestgaard, B. G., Tybjærg-Hansen, A., & Thomassen, J. Q. (2022).
Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease.
Alzheimer's and Dementia,
18(12), 2734-2735.
https://doi.org/10.1002/alz.12742
Vancouver
Frikke-Schmidt R, Hegazy SH, Rasmussen IJ
, Nordestgaard BG, Tybjærg-Hansen A, Thomassen JQ.
Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease.
Alzheimer's and Dementia. 2022;18(12): 2734-2735.
https://doi.org/10.1002/alz.12742
Author
Frikke-Schmidt, Ruth ; Hegazy, Sharif H. ; Rasmussen, Ida Juul ; Nordestgaard, Børge G. ; Tybjærg-Hansen, Anne ; Thomassen, Jesper Qvist. / Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease. In: Alzheimer's and Dementia. 2022 ; Vol. 18, No. 12. pp. 2734-2735.
Bibtex
@article{fc69b7cb109b432697007cad9a48c7b1,
title = "Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease",
author = "Ruth Frikke-Schmidt and Hegazy, {Sharif H.} and Rasmussen, {Ida Juul} and Nordestgaard, {B{\o}rge G.} and Anne Tybj{\ae}rg-Hansen and Thomassen, {Jesper Qvist}",
note = "Funding Information: Sharif H. Hegazy, Jesper Qvist Thomassen, Ida Juul Rasmussen, and Anne Tybj{\ae}rg‐Hansen have nothing to disclose. B{\o}rge G. Nordestgaard received consulting fees (personal fees) from AstraZeneca, Sanofi, Regeneron, Akcea, Amgen, Kowa, Denka, Amarin, Novartis, Novo Nordisk, Esperion, and Silence Therapeutics. RFS received consulting fees (personal fees) from Novo Nordisk. The Lundbeck Foundation, the Danish Heart Foundation, and the Independent Research Fund Denmark. Author disclosures are available in the supporting information.",
year = "2022",
doi = "10.1002/alz.12742",
language = "English",
volume = "18",
pages = " 2734--2735",
journal = "Alzheimer's & Dementia",
issn = "1552-5260",
publisher = "Elsevier",
number = "12",
}
RIS
TY - JOUR
T1 - Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease
AU - Frikke-Schmidt, Ruth
AU - Hegazy, Sharif H.
AU - Rasmussen, Ida Juul
AU - Nordestgaard, Børge G.
AU - Tybjærg-Hansen, Anne
AU - Thomassen, Jesper Qvist
N1 - Funding Information:
Sharif H. Hegazy, Jesper Qvist Thomassen, Ida Juul Rasmussen, and Anne Tybjærg‐Hansen have nothing to disclose. Børge G. Nordestgaard received consulting fees (personal fees) from AstraZeneca, Sanofi, Regeneron, Akcea, Amgen, Kowa, Denka, Amarin, Novartis, Novo Nordisk, Esperion, and Silence Therapeutics. RFS received consulting fees (personal fees) from Novo Nordisk. The Lundbeck Foundation, the Danish Heart Foundation, and the Independent Research Fund Denmark. Author disclosures are available in the supporting information.
PY - 2022
Y1 - 2022
U2 - 10.1002/alz.12742
DO - 10.1002/alz.12742
M3 - Comment/debate
C2 - 35988061
AN - SCOPUS:85136460684
VL - 18
SP - 2734
EP - 2735
JO - Alzheimer's & Dementia
JF - Alzheimer's & Dementia
SN - 1552-5260
IS - 12
ER -
